Answers are grounded in this paper and cite their sources.
Randomized trial shows improved oxygen saturation and exercise capacity in interstitial lung disease patients, suggesting effective management with methylprednisolone.
Methylprednisolone improved oxygen saturation, FVC, exercise capacity, and radiological resolution in patients with post-COVID-19 ILD compared to the natural course of the disease.
No takes yet. Share an insight, caveat, or question.
Yüksel et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: